REG-BARCLAYS PLC Form 8.3 - WILLIS TOWERS WATSON PLC - Amendment
14/01/2021 09:05
For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20210114:nBw3hyTGva&default-theme=true
Form 8.3 - WILLIS TOWERS WATSON PLC - Amendment
Ap19
FORM 8.3 - Amendment to Purchase
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER
RULES, 2013
DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR
MORE
1. KEY INFORMATION
Name of person dealing (Note 1) Barclays PLC.
Company dealt in WILLIS TOWERS WATSON PLC
Class of relevant security to which the ORD
dealings being disclosed relate (Note 2)
Date of dealing 07 January 2021
2. INTERESTS AND SHORT POSITIONS
(a) Interests and short positions (following dealing) in the class of relevant
security dealt in (Note 3)
Class of relevant security: ORD
Long Short
Number (%) Number (%)
(1) Relevant securities
2,963,252 2.30% 680,810 0.53%
(2) Derivatives (other than options):
354,221 0.27% 744,601 0.58%
(3) Options and agreements to
purchase/sell: 0 0.00% 0 0.00%
TOTAL:
3,317,473 2.57% 1,425,411 1.11%
(b) Interests and short positions in relevant securities of the company, other
than the class dealt in (Note 3)
Class of relevant security: Long Short
Number (%) Number (%)
(1) Relevant securities
(2) Derivatives (other than options)
(3) Options and agreements to purchase/sell
Total
Ap20
1. DEALINGS (Note 4)
(a) Purchases and sales
Purchase/sale Number of relevant securities Price per unit
Purchase 1 206.1700 USD
Purchase 1 205.2600 USD
Purchase 3 203.6000 USD
Purchase 6 205.9875 USD
Purchase 10 205.8100 USD
Purchase 15 204.7700 USD
Purchase 19 206.4205 USD
Purchase 59 203.8300 USD
Purchase 79 205.7563 USD
Purchase 100 205.0200 USD
Purchase 101 206.0411 USD
Purchase 265 205.7389 USD
Purchase 273 203.9041 USD
Purchase 400 205.7287 USD
Purchase 600 204.4933 USD
Purchase 851 205.2875 USD
Purchase 900 205.6572 USD
Purchase 1,004 205.9182 USD
Purchase 1,100 205.7318 USD
Purchase 1,200 205.4754 USD
Purchase 1,531 205.9109 USD
Purchase 1,594 205.6766 USD
Purchase 1,999 205.2503 USD
Purchase 2,600 205.2785 USD
Purchase 4,324 205.2642 USD
Purchase 4,661 205.2500 USD
Purchase 11,958 205.0993 USD
Purchase 15,014 205.1892 USD
Purchase 15,093 205.2649 USD
Purchase 22,814 206.0646 USD
Purchase 25,197 205.6878 USD
Purchase 29,651 205.5576 USD
Purchase 38,246 205.7285 USD
Sale 1 205.4600 USD
Sale 1 206.1700 USD
Sale 1 205.6600 USD
Sale 1 205.8500 USD
Sale 2 205.9550 USD
Sale 2 205.7750 USD
Sale 4 206.1000 USD
Sale 10 205.8100 USD
Sale 12 206.0583 USD
Sale 12 206.0700 USD
Sale 19 206.4205 USD
Sale 53 205.4543 USD
Sale 56 204.9925 USD
Sale 56 205.1800 USD
Sale 56 205.5975 USD
Sale 70 205.2760 USD
Sale 74 205.2202 USD
Sale 86 205.2709 USD
Sale 86 205.1460 USD
Sale 93 206.0000 USD
Sale 99 205.1931 USD
Sale 100 206.0100 USD
Sale 108 205.2689 USD
Sale 168 205.2116 USD
Sale 200 205.7950 USD
Sale 200 206.0650 USD
Sale 258 206.0868 USD
Sale 278 203.9412 USD
Sale 304 206.0124 USD
Sale 422 206.0322 USD
Sale 604 206.0198 USD
Sale 788 205.9102 USD
Sale 946 206.0408 USD
Sale 1,024 206.0601 USD
Sale 1,126 205.6397 USD
Sale 1,148 205.2292 USD
Sale 1,500 205.1513 USD
Sale 1,562 205.8863 USD
Sale 1,626 205.8067 USD
Sale 1,665 205.6473 USD
Sale 1,686 205.5503 USD
Sale 1,732 206.0883 USD
Sale 1,765 205.5291 USD
Sale 1,899 205.5805 USD
Sale 1,974 205.8032 USD
Sale 2,001 205.2508 USD
Sale 2,756 205.6893 USD
Sale 2,971 206.0794 USD
Sale 2,984 205.7850 USD
Sale 3,000 206.0753 USD
Sale 3,938 205.5350 USD
Sale 3,995 205.3380 USD
Sale 4,433 206.0691 USD
Sale 4,454 205.2500 USD
Sale 6,956 205.2215 USD
Sale 7,673 206.0552 USD
Sale 8,076 205.1600 USD
Sale 8,097 205.4957 USD
Sale 9,241 204.8964 USD
Sale 13,964 205.2695 USD
Sale 19,925 205.6555 USD
Sale 53,100 205.6684 USD
(b) Derivatives transactions (other than options transactions)
Product name, Nature of transaction Number of relevant securities Price per unit
e.g. CFD (Note 6) (Note 7) (Note 5)
(c) Options transactions in respect of existing relevant securities
(i) Writing, selling, purchasing or varying
Product name, Writing, selling, purchasing, varying etc. Number of securities to which the option relates (Note 7) Exercise price Type, e.g. American, European etc. Expiry date Option money paid/received per unit (Note 5)
e.g. call option
(ii) Exercising
Product name, Number of securities Exercise price per unit (Note 5)
e.g. call option
(d) Other dealings (including transactions in respect of new securities) (Note
4)
Nature of transaction Details Price per unit
(Note 8) (if applicable) (Note 5)
Ap21
2. OTHER INFORMATION
Agreements, arrangements or understandings relating to options or derivatives
Full details of any agreement, arrangement or understanding between the person disclosing
and any other person relating to the voting rights of any relevant securities under any option
referred to on this form or relating to the voting rights or future acquisition or disposal of any
relevant securities to which any derivative referred to on this form is referenced. If none, this
should be stated.
NONE
Is a Supplemental Form 8 (Open Positions) attached? NO
Date of disclosure: 14 Jan 2021
Contact name: Large Holdings Regulatory Operations
Telephone number: 020 3134 7213
If a connected EFM, name of offeree/offeror with which connected
If a connected EFM, state nature of connection
View source version on businesswire.com:
https://www.businesswire.com/news/home/20210114005417/en/
(https://www.businesswire.com/news/home/20210114005417/en/)
BARCLAYS PLC
Copyright Business Wire 2021Recent news on Barclays
See all newsREG - Barclays PLC Just Group plc - Form 8.3 JUST GROUP PLC
AnnouncementREG - Barclays PLC NCC Group PLC - Form 8.3 NCC GROUP PLC
AnnouncementREG - Barclays PLC Spire Healthcare Grp - Form 8.3 SPIRE HEALTHCARE GROUP PLC
AnnouncementREG - Barclays PLC Life Science REIT - Form 8.3 LIFE SCIENCE REIT PLC
AnnouncementREG - Barclays PLC British Land Co PLC - Form 8.3 BRITISH LAND COMPANY PLC, THE
Announcement